Company

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals develops antibiotics, including treatments for drug-resistant bacterial infections.

About

Founded in 2006 and based in Waltham, Massachusetts, US, Tetraphase Pharmaceuticals focused on developing antibiotics for serious bacterial infections. It raised USD 75 mn in an IPO in March 2013. In May 2020, AcelRx Pharmaceuticals, Inc. held acquisition discussions with the company for USD 44.50 mn.

4Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in